These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

923 related items for PubMed ID: 17875243

  • 1. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, Zisapel N.
    Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
    [Abstract] [Full Text] [Related]

  • 2. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
    Wade AG, Crawford G, Ford I, McConnachie A, Nir T, Laudon M, Zisapel N.
    Curr Med Res Opin; 2011 Jan; 27(1):87-98. PubMed ID: 21091391
    [Abstract] [Full Text] [Related]

  • 3. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
    Lemoine P, Nir T, Laudon M, Zisapel N.
    J Sleep Res; 2007 Dec; 16(4):372-80. PubMed ID: 18036082
    [Abstract] [Full Text] [Related]

  • 4. [Controlled release melatonin (Circadin) in the treatment of insomnia in older patients: efficacy and safety in patients with history of use and non-use of hypnotic drugs].
    Zisapel N.
    Harefuah; 2009 May; 148(5):337-41, 348. PubMed ID: 19630367
    [Abstract] [Full Text] [Related]

  • 5. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.
    Luthringer R, Muzet M, Zisapel N, Staner L.
    Int Clin Psychopharmacol; 2009 Sep; 24(5):239-49. PubMed ID: 19584739
    [Abstract] [Full Text] [Related]

  • 6. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T.
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [Abstract] [Full Text] [Related]

  • 7. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement.
    Hughes RJ, Sack RL, Lewy AJ.
    Sleep; 1998 Jul; 21(1):52-68. PubMed ID: 9485533
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
    Lydiard RB, Lankford DA, Seiden DJ, Landin R, Farber R, Walsh JK.
    J Clin Sleep Med; 2006 Jul 15; 2(3):309-15. PubMed ID: 17561543
    [Abstract] [Full Text] [Related]

  • 9. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
    Mini LJ, Wang-Weigand S, Zhang J.
    Am J Geriatr Pharmacother; 2007 Sep 15; 5(3):177-84. PubMed ID: 17996657
    [Abstract] [Full Text] [Related]

  • 10. A polysomnography study of eszopiclone in elderly patients with insomnia.
    McCall WV, Erman M, Krystal AD, Rosenberg R, Scharf M, Zammit GK, Wessel T.
    Curr Med Res Opin; 2006 Sep 15; 22(9):1633-42. PubMed ID: 16968566
    [Abstract] [Full Text] [Related]

  • 11. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial.
    Soares CN, Joffe H, Rubens R, Caron J, Roth T, Cohen L.
    Obstet Gynecol; 2006 Dec 15; 108(6):1402-10. PubMed ID: 17138773
    [Abstract] [Full Text] [Related]

  • 12. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM, Lee KA, Scharf MB.
    Clin Ther; 2004 Oct 15; 26(10):1578-86. PubMed ID: 15598474
    [Abstract] [Full Text] [Related]

  • 13. Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients.
    Tarrasch R, Laudon M, Zisapel N.
    Hum Psychopharmacol; 2003 Dec 15; 18(8):603-10. PubMed ID: 14696019
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug 15; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 15. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P.
    Sleep Med; 2006 Jun 15; 7(4):312-8. PubMed ID: 16709464
    [Abstract] [Full Text] [Related]

  • 16. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia.
    Van der Heijden KB, Smits MG, Van Someren EJ, Ridderinkhof KR, Gunning WB.
    J Am Acad Child Adolesc Psychiatry; 2007 Feb 15; 46(2):233-41. PubMed ID: 17242627
    [Abstract] [Full Text] [Related]

  • 17. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG, Ford I, Crawford G, McConnachie A, Nir T, Laudon M, Zisapel N.
    BMC Med; 2010 Aug 16; 8():51. PubMed ID: 20712869
    [Abstract] [Full Text] [Related]

  • 18. Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial.
    Smits MG, van Stel HF, van der Heijden K, Meijer AM, Coenen AM, Kerkhof GA.
    J Am Acad Child Adolesc Psychiatry; 2003 Nov 16; 42(11):1286-93. PubMed ID: 14566165
    [Abstract] [Full Text] [Related]

  • 19. Effect of melatonin-rich night-time milk on sleep and activity in elderly institutionalized subjects.
    Valtonen M, Niskanen L, Kangas AP, Koskinen T.
    Nord J Psychiatry; 2005 Nov 16; 59(3):217-21. PubMed ID: 16195124
    [Abstract] [Full Text] [Related]

  • 20. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
    Erman M, Seiden D, Zammit G, Sainati S, Zhang J.
    Sleep Med; 2006 Jan 16; 7(1):17-24. PubMed ID: 16309958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.